Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | GDC-0084 |
| Trade Name | |
| Synonyms | GDC0084|Paxalisib |
| Drug Descriptions |
Paxalisib (GDC-0084) is a dual pan-PI3K and mTOR inhibitor, which prevents cell proliferation and potentially inhibits tumor growth (PMID: 22619466, PMID: 32269051, PMID: 31937616). |
| DrugClasses | mTOR Inhibitor 51 PI3K Inhibitor (Pan) 42 |
| CAS Registry Number | 1382979-44-3 |
| NCIT ID | C116877 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Dordaviprone + GDC-0084 | Dordaviprone GDC-0084 | 0 | 1 |
| GDC-0084 | GDC-0084 | 1 | 7 |
| GDC-0084 + Irinotecan + Temozolomide | GDC-0084 Irinotecan Temozolomide | 0 | 1 |
| GDC-0084 + Metformin | GDC-0084 Metformin | 0 | 1 |
| GDC-0084 + Trastuzumab | GDC-0084 Trastuzumab | 0 | 1 |